Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma

In patients with resected metastatic melanoma, shorter treatment duration with anti-PD1 antibodies is not associated with a worse outcome.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-03-22
DOI
https://doi.org/10.1111/jdv.20650
Citations
1
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma

Patrick Terheyden, Bastian Schilling, Edgar Dippel, Rudolf Alexander Herbst et al.
1 citations
Journal of the European Academy of Dermatology and Venereology
Cutaneous Melanoma Detection and Management
1.05
article

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma

Patrick Terheyden, Bastian Schilling, Edgar Dippel, Rudolf Alexander Herbst, Ralf Gutzmer, Michael Weichenthal, Claudia Pföhler, Dirk Schadendorf, Friedegund Meier, Ricarda Rauschenberg, Elisabeth Livingstone, Peter J. Mohr, Carola Berking, Selma Ugurel, Frank Meiß, Fiona Brunnert, Lisa Zimmer, Jessica Cecile Hassel, Dirk Tomsitz, Carmen Loquai, Alexander Kreuter, Ulrike Leiter, Martin Kaatz, Imke von Wasielewski, Michael Sachse, Lucie Heinzerling, Jens Ulrich
article en
1 citations

Abstract

In patients with resected metastatic melanoma, shorter treatment duration with anti-PD1 antibodies is not associated with a worse outcome.

Journal of the European Academy of Dermatology and VenereologyVol. 39(11)
University of Freiburg (DE), German Cancer Research Center (DE), Heidelberg University (DE), Hohenstein Institute (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), National Center for Tumor Diseases (DE), University Hospital Schleswig-Holstein (DE), Essen University Hospital (DE), HELIOS St. Elisabeth Klinik Oberhausen (DE), Universitätsklinikum Würzburg (DE), Klinikum Ludwigshafen (DE), Elbe Kliniken Stade-Buxtehude (DE), Klinikum Bremerhaven-Reinkenheide (DE), Helios Klinikum Erfurt (DE), Comprehensive Cancer Center Erlangen (DE), DAK-Gesundheit (Germany) (DE), University Hospital Carl Gustav Carus (DE), Johannes Wesling Klinikum Minden (DE), Deutsches Konsortium für Translationale Krebsforschung (DE), University of Duisburg-Essen (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), Ruhr University Bochum (DE), Saarland University (DE), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 24%
Cutaneous Melanoma Detection and Management
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.